Ritonavir CBZ 1088

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 1 dose
200 mg daily TID
Drug 1 effect

Decreased ritonavir levels)

Drug 2
Drug 2 dose
350 mg BID
Drug 2 effect

Not studied (may increase carbamazepine levels)

Clinical Effects

Increased carbamazepine effects; decreased ritonavir effects

Management

Avoid combination and use alternative agents. If coadministering monitor carbamazepine levels and adjust as indicated. Monitor antiviral efficacy

Alternative Agents
Gabapentin Lamotrigine Tiagabine Topiramate
Import ID
1088